You are currently viewing a new version of our website. To view the old version click .

Pharmaceuticals, Volume 18, Issue 10

October 2025 - 114 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (114)

  • Article
  • Open Access

Characterization of O-Glycosylation and N-Glycosylation in Bispecific Antibodies and Its Importance in Therapeutic Antibody Development

  • Maoqin Duan,
  • Luyun Guo,
  • Zhen Long,
  • Yongbo Ni,
  • Yalan Yang,
  • Jialiang Du,
  • Meng Li,
  • Jialing Zhang,
  • Tao Tang and
  • Chuanfei Yu
  • + 1 author
Pharmaceuticals2025, 18(10), 1538;https://doi.org/10.3390/ph18101538 
(registering DOI)

13 October 2025

Background/Objectives: This study comprehensively characterized the O- and N-glycosylation profiles of bispecific antibodies (BsAbs) via advanced analytical techniques to evaluate their structural and functional implications. Methods: High-resolution...

  • Review
  • Open Access
Pharmaceuticals2025, 18(10), 1536;https://doi.org/10.3390/ph18101536 
(registering DOI)

13 October 2025

Background: Inflammatory Bowel Disease (IBD), including Ulcerative Colitis and Crohn’s Disease, is a multifactorial inflammatory condition of the intestinal tract driven by a complex interplay of genetic factors, immune system dysfunction, and...

  • Article
  • Open Access

The Hepatoprotective Properties of the Revised Formulation of Dahuang Xiaoshi Tang, an Ancient Chinese Herbal Decoction, Are Probed by Integrated Metabolomics and Network Pharmacology

  • Xiangpeng Kong,
  • Xiaoyang Wang,
  • Haiqin Ren,
  • Yajun Yao,
  • Hui Zhang,
  • Huifeng Li,
  • Huifang Li,
  • Yangang Cheng,
  • Zhuqing Song and
  • Miaorong Pei
  • + 1 author

13 October 2025

Background: Dahuang Xiaoshi Tang (DXT), an ancient Chinese herbal remedy dating back to 220 AD, as documented initially in “Treatise on Febrile and Miscellaneous Diseases,” is used to treat damp-heat jaundice with interior sthenia syndrom...

  • Systematic Review
  • Open Access

Impact of the COVID-19 Pandemic on Drug-Resistant Tuberculosis in Europe: A Meta-Analysis of Epidemiological Trends

  • Christina Zouganeli,
  • Dimitra K. Toubanaki,
  • Ourania Karaoulani,
  • Georgia Vrioni,
  • Evdokia Karagouni and
  • Antonia Efstathiou
Pharmaceuticals2025, 18(10), 1535;https://doi.org/10.3390/ph18101535 
(registering DOI)

12 October 2025

Background/Objectives: The COVID-19 pandemic has significantly intensified global concerns surrounding antimicrobial resistance (AMR), particularly in relation to tuberculosis (TB). In the European Union (EU), the reallocation of healthcare resources...

  • Article
  • Open Access

12 October 2025

Background/Objectives: This study aimed to synthesize a novel, high-molecular-weight acyclic heterocyclic compound, compound 5, via a one-pot reaction between Trichloroisocyanuric acid (TCCA) and ethanolamine, and evaluate its anticancer, antioxidant...

  • Article
  • Open Access

New-Onset Diabetes After Transplantation in Renal Recipients: A Pilot Comparative Study of Immediate vs. Extended-Release Tacrolimus Formulation

  • Ioana Adela Ratiu,
  • Florin Bănică,
  • Corina Moisa,
  • Bianca Pașca,
  • Daniela Gîtea,
  • Iulia Dana Grosu,
  • Gabriel Cristian Bako,
  • Oliviu Voștinaru,
  • Wael Abu Dayyih and
  • Lorena Filip
Pharmaceuticals2025, 18(10), 1532;https://doi.org/10.3390/ph18101532 
(registering DOI)

12 October 2025

Tacrolimus is frequently used in immunosuppressive therapy in renal transplant patients and is characterized by high toxicity, a low therapeutic index, and great individual variability. For these reasons, correct dosing is important to ensure patient...

  • Article
  • Open Access

Resensitizing the Untreatable: Zidovudine and Polymyxin Combinations to Combat Pan-Drug-Resistant Klebsiella pneumoniae

  • Jan Naseer Kaur,
  • Jack F. Klem,
  • Gebremedhin S. Hailu,
  • Nader N. Nasief,
  • Yang Liu,
  • Allison Hanna,
  • Albert Chen,
  • Patricia Holden,
  • Shivali Kapoor and
  • Nicholas M. Smith
  • + 3 authors

11 October 2025

Background: The emergence of pan-drug-resistant (PDR) Klebsiella pneumoniae has compromised the efficacy of last-line agents, leaving few therapeutic options. Repurposing zidovudine, an FDA-approved thymidine analog with antibacterial activity, may e...

  • Article
  • Open Access

Predictive Value of Baseline Left Ventricular Global Longitudinal Strain for Cardiac Dysfunction in Patients with Moderate to High Risk of Cancer Therapy-Related Cardiovascular Toxicity

  • Anna Borowiec,
  • Patrycja Ozdowska,
  • Magdalena Rosinska,
  • Agnieszka Maria Zebrowska,
  • Slawomir Jasek,
  • Beata Kotowicz,
  • Hanna Kosela-Paterczyk,
  • Elzbieta Lampka,
  • Zbigniew Nowecki and
  • Jan Walewski

11 October 2025

Background: Anthracycline-based chemotherapy is associated with a risk of cancer therapy-related cardiac dysfunction (CTRCD), particularly in patients with moderate to high cardiovascular risk. Left ventricular global longitudinal strain (GLS) is a s...

  • Review
  • Open Access

11 October 2025

Ginsenosides, the primary bioactive components of Panax ginseng, have demonstrated significant immunomodulatory potential. While major ginsenosides have been extensively studied, rare ginsenosides produced through deglycosylation, heating, and steami...

of 12